Side effects of prenatal treatment for congenital toxoplasmosis;Effets secondaires du traitement anténatal de la toxoplasmose congénitale

Presse Medicale

Volumn 34, Issue 22 I, 2005, Pages 1719-

  Chemla, C ^a,b   Villena, I ^a,b   Trenque, T ^a,b   Pinon, J M ^a,b  

^a HÔPITAL MAISON BLANCHE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR; FOLIC ACID; FOLINATE CALCIUM; PYRIMETHAMINE SULFADIAZINE;

CONGENITAL TOXOPLASMOSIS; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; LETTER; MOTHER FETUS RELATIONSHIP; PANCYTOPENIA; PREGNANCY; PRENATAL DIAGNOSIS; SUPPLEMENTATION;

EID: 33344475967     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(05)84259-9     Document Type: Letter

References (7)

1. Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Scand J Infec Dis 1998; 30: 295-300.
2. Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 2004; 113: 1567-72.
3. Dorangeon PH, Marx-Chemla C, Quereux C, Fay R, Leroux B, Choisy H et al. Les risques de l'association pyrimethamine-sulfadoxine dans le traitement anténatal de la toxoplasmose. J Gynecol Obstet/Biol Reprod 1992; 21: 549-56.
4. Trenque T, Marx C, Quereux C, Leroux B, Dupouy D, Dorangeon PH et al. Human maternofoetal distribution of pyrimethamine-sulfadoxine. Br J Clin Pharmacol 1998; 45: 179-80.
5. Trenque T, Simon N, Villena I, Chemla C, Quereux C, Leroux B et al. Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis. Br J Clin Pharmacol 2004; 57: 735-41.
6. Hezard N, Marx-Chemla C, Foudrinier F, Villena I, Quereux C, Leroux B et al. Prenatal diagnosis of congenital toxoplasmosis in 261 pregancies. Prenat Disgn 1997; 17: 1047-54.
7. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999; 180: 410-15.